Cargando…
Evaluation of radiation maculopathy after treatment of choroidal melanoma with ruthenium-106 using optical coherence tomography angiography
BACKGROUND: To assess the impact of brachytherapy on macular microvasculature utilizing optical coherence tomography angiography (OCTA) in treated choroidal melanoma. METHODS: In this retrospective observational case series, we reviewed the recorded data of the patients with unilateral extramacular...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562000/ https://www.ncbi.nlm.nih.gov/pubmed/34727878 http://dx.doi.org/10.1186/s12886-021-02140-w |
_version_ | 1784593181449388032 |
---|---|
author | Torkashvand, Ali Riazi-Esfahani, Hamid Ghassemi, Fariba Khalili Pour, Elias Masoomian, Babak Zarei, Mohammad Fadakar, Kaveh Arjmand, Mojtaba Tayebi, Fereshteh Ekradi, Leila Abrishami Moghaddam, Hamid Mahmoudi, Tahereh Daneshmand, Reihaneh Faghihi, Hooshang |
author_facet | Torkashvand, Ali Riazi-Esfahani, Hamid Ghassemi, Fariba Khalili Pour, Elias Masoomian, Babak Zarei, Mohammad Fadakar, Kaveh Arjmand, Mojtaba Tayebi, Fereshteh Ekradi, Leila Abrishami Moghaddam, Hamid Mahmoudi, Tahereh Daneshmand, Reihaneh Faghihi, Hooshang |
author_sort | Torkashvand, Ali |
collection | PubMed |
description | BACKGROUND: To assess the impact of brachytherapy on macular microvasculature utilizing optical coherence tomography angiography (OCTA) in treated choroidal melanoma. METHODS: In this retrospective observational case series, we reviewed the recorded data of the patients with unilateral extramacular choroidal melanoma treated with ruthenium − 106 ((106)Ru) plaque radiotherapy with a follow-up period of more than 6 months. Automatically measured OCTA retinal parameters were analysed after image processing. RESULTS: Thirty-one eyes of 31 patients with the mean age of 51.1 years were recruited. Six eyes had no radiation maculopathy (RM). From 25 eyes with RM, nine eyes (36%) revealed a burnout macular microvasculature with imperceptible vascular details. Twenty-one non-irradiated fellow eyes from the enrolled patients were considered as the control group. Foveal and optic disc radiation dose had the highest value to predict the burnout pattern (ROC, AUC: 0.763, 0.727). Superficial and deep foveal avascular zone (FAZ) were larger in irradiated eyes in comparison to non-irradiated fellow eyes (1629 μm(2) vs. 428 μm(2), P = 0.005; 1837 μm(2) vs 268 μm(2), P = 0.021; respectively). Foveal and parafoveal vascular area density (VAD) and vascular skeleton density (VSD) in both superficial and deep capillary plexus (SCP and DCP) were decreased in all irradiated eyes in comparison with non-irradiated fellow eyes (P < 0.001). Compared with non-irradiated fellow eyes, irradiated eyes without RM had significantly lower VAD and VSD at foveal and parafoveal DCP (all P < 0.02). However, these differences at SCP were not statistically significant. CONCLUSION: The OCTA is a valuable tool for evaluating RM. Initial subclinical microvascular insult after (106)Ru brachytherapy is more likely to occur in DCP. The deep FAZ area was identified as a more critical biomarker of BCVA than superficial FAZ in these patients. |
format | Online Article Text |
id | pubmed-8562000 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-85620002021-11-03 Evaluation of radiation maculopathy after treatment of choroidal melanoma with ruthenium-106 using optical coherence tomography angiography Torkashvand, Ali Riazi-Esfahani, Hamid Ghassemi, Fariba Khalili Pour, Elias Masoomian, Babak Zarei, Mohammad Fadakar, Kaveh Arjmand, Mojtaba Tayebi, Fereshteh Ekradi, Leila Abrishami Moghaddam, Hamid Mahmoudi, Tahereh Daneshmand, Reihaneh Faghihi, Hooshang BMC Ophthalmol Research BACKGROUND: To assess the impact of brachytherapy on macular microvasculature utilizing optical coherence tomography angiography (OCTA) in treated choroidal melanoma. METHODS: In this retrospective observational case series, we reviewed the recorded data of the patients with unilateral extramacular choroidal melanoma treated with ruthenium − 106 ((106)Ru) plaque radiotherapy with a follow-up period of more than 6 months. Automatically measured OCTA retinal parameters were analysed after image processing. RESULTS: Thirty-one eyes of 31 patients with the mean age of 51.1 years were recruited. Six eyes had no radiation maculopathy (RM). From 25 eyes with RM, nine eyes (36%) revealed a burnout macular microvasculature with imperceptible vascular details. Twenty-one non-irradiated fellow eyes from the enrolled patients were considered as the control group. Foveal and optic disc radiation dose had the highest value to predict the burnout pattern (ROC, AUC: 0.763, 0.727). Superficial and deep foveal avascular zone (FAZ) were larger in irradiated eyes in comparison to non-irradiated fellow eyes (1629 μm(2) vs. 428 μm(2), P = 0.005; 1837 μm(2) vs 268 μm(2), P = 0.021; respectively). Foveal and parafoveal vascular area density (VAD) and vascular skeleton density (VSD) in both superficial and deep capillary plexus (SCP and DCP) were decreased in all irradiated eyes in comparison with non-irradiated fellow eyes (P < 0.001). Compared with non-irradiated fellow eyes, irradiated eyes without RM had significantly lower VAD and VSD at foveal and parafoveal DCP (all P < 0.02). However, these differences at SCP were not statistically significant. CONCLUSION: The OCTA is a valuable tool for evaluating RM. Initial subclinical microvascular insult after (106)Ru brachytherapy is more likely to occur in DCP. The deep FAZ area was identified as a more critical biomarker of BCVA than superficial FAZ in these patients. BioMed Central 2021-11-02 /pmc/articles/PMC8562000/ /pubmed/34727878 http://dx.doi.org/10.1186/s12886-021-02140-w Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Torkashvand, Ali Riazi-Esfahani, Hamid Ghassemi, Fariba Khalili Pour, Elias Masoomian, Babak Zarei, Mohammad Fadakar, Kaveh Arjmand, Mojtaba Tayebi, Fereshteh Ekradi, Leila Abrishami Moghaddam, Hamid Mahmoudi, Tahereh Daneshmand, Reihaneh Faghihi, Hooshang Evaluation of radiation maculopathy after treatment of choroidal melanoma with ruthenium-106 using optical coherence tomography angiography |
title | Evaluation of radiation maculopathy after treatment of choroidal melanoma with ruthenium-106 using optical coherence tomography angiography |
title_full | Evaluation of radiation maculopathy after treatment of choroidal melanoma with ruthenium-106 using optical coherence tomography angiography |
title_fullStr | Evaluation of radiation maculopathy after treatment of choroidal melanoma with ruthenium-106 using optical coherence tomography angiography |
title_full_unstemmed | Evaluation of radiation maculopathy after treatment of choroidal melanoma with ruthenium-106 using optical coherence tomography angiography |
title_short | Evaluation of radiation maculopathy after treatment of choroidal melanoma with ruthenium-106 using optical coherence tomography angiography |
title_sort | evaluation of radiation maculopathy after treatment of choroidal melanoma with ruthenium-106 using optical coherence tomography angiography |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562000/ https://www.ncbi.nlm.nih.gov/pubmed/34727878 http://dx.doi.org/10.1186/s12886-021-02140-w |
work_keys_str_mv | AT torkashvandali evaluationofradiationmaculopathyaftertreatmentofchoroidalmelanomawithruthenium106usingopticalcoherencetomographyangiography AT riaziesfahanihamid evaluationofradiationmaculopathyaftertreatmentofchoroidalmelanomawithruthenium106usingopticalcoherencetomographyangiography AT ghassemifariba evaluationofradiationmaculopathyaftertreatmentofchoroidalmelanomawithruthenium106usingopticalcoherencetomographyangiography AT khalilipourelias evaluationofradiationmaculopathyaftertreatmentofchoroidalmelanomawithruthenium106usingopticalcoherencetomographyangiography AT masoomianbabak evaluationofradiationmaculopathyaftertreatmentofchoroidalmelanomawithruthenium106usingopticalcoherencetomographyangiography AT zareimohammad evaluationofradiationmaculopathyaftertreatmentofchoroidalmelanomawithruthenium106usingopticalcoherencetomographyangiography AT fadakarkaveh evaluationofradiationmaculopathyaftertreatmentofchoroidalmelanomawithruthenium106usingopticalcoherencetomographyangiography AT arjmandmojtaba evaluationofradiationmaculopathyaftertreatmentofchoroidalmelanomawithruthenium106usingopticalcoherencetomographyangiography AT tayebifereshteh evaluationofradiationmaculopathyaftertreatmentofchoroidalmelanomawithruthenium106usingopticalcoherencetomographyangiography AT ekradileila evaluationofradiationmaculopathyaftertreatmentofchoroidalmelanomawithruthenium106usingopticalcoherencetomographyangiography AT abrishamimoghaddamhamid evaluationofradiationmaculopathyaftertreatmentofchoroidalmelanomawithruthenium106usingopticalcoherencetomographyangiography AT mahmouditahereh evaluationofradiationmaculopathyaftertreatmentofchoroidalmelanomawithruthenium106usingopticalcoherencetomographyangiography AT daneshmandreihaneh evaluationofradiationmaculopathyaftertreatmentofchoroidalmelanomawithruthenium106usingopticalcoherencetomographyangiography AT faghihihooshang evaluationofradiationmaculopathyaftertreatmentofchoroidalmelanomawithruthenium106usingopticalcoherencetomographyangiography |